Država: Sjedinjene Američke Države
Jezik: engleski
Izvor: NLM (National Library of Medicine)
DICLOFENAC SODIUM (UNII: QTG126297Q) (DICLOFENAC - UNII:144O8QL0L1)
Sircle Laboratories, LLC
DICLOFENAC SODIUM
DICLOFENAC SODIUM 16.05 mg in 1 mL
TOPICAL
PRESCRIPTION DRUG
Diclofenac sodium topical solution is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s). Diclofenac sodium topical solution is contraindicated in patients with a known hypersensitivity to diclofenac sodium or any other component of diclofenac sodium topical solution. Diclofenac sodium topical solution is contraindicated in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.7, 5.10)]. Diclofenac sodium topical solution is contraindicated in the setting of coronary artery bypass graft (CABG) surgery [see Warnings and Precautions (5.1)]. Pregnancy Category C prior to 30 weeks gestation; Category D starting 30 weeks gestation. Teratogenic Effects: There are no adequate and well-controlled studies of diclofenac sodium topical solution in pregnant w
Diclofenac Sodium Topical Solution is supplied as a clear, colorless to faintly pink-orange solution containing 16.05 mg of diclofenac sodium per mL of solution, in a white high density polyethylene bottle with a white low-density dropper cap. Storage Store at 25°C (77°F); excursions permitted to 15° to 30° C (59° to 86° F) [See USP Controlled Room Temperature].
Abbreviated New Drug Application
Sircle Laboratories, LLC ---------- Please refer to the package insert for more information Revised: 12/2018 Document Id: 7d4f42aa-5036-2484-e053-2991aa0ad9c4 34391-3 Set id: 22b24f35-9ff5-4950-e054-00144ff88e88 Version: 3 Effective Time: 20181218 Sircle Laboratories, LLC Pročitajte cijeli dokument
DICLOFENAC SODIUM- DICLOFENAC SODIUM SOLUTION SIRCLE LABORATORIES, LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE DICLOFENAC SODIUM TOPICAL SOLUTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR DICLOFENAC SODIUM TOPICAL SOLUTION. DICLOFENAC SODIUM TOPICAL SOLUTION 1.5% W/W IS FOR TOPICAL USE ONLY. INITIAL U.S. APPROVAL: 1988 WARNING: CARDIOVASCULAR AND GASTROINTESTINAL RISK SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING CARDIOVASCULAR RISK NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MAY CAUSE AN INCREASED RISK OF SERIOUS CARDIOVASCULAR THROMBOTIC EVENTS, MYOCARDIAL INFARCTION, AND STROKE, WHICH CAN BE FATAL. PATIENTS WITH CARDIOVASCULAR DISEASE OR RISK FACTORS FOR CARDIOVASCULAR DISEASE MAY BE AT GREATER RISK. ( 5.1) DICLOFENAC SODIUM TOPICAL SOLUTION IS CONTRAINDICATED FOR THE TREATMENT OF PERIOPERATIVE PAIN IN THE SETTING OF CORONARY ARTERY BYPASS GRAFT (CABG) SURGERY. ( 4 ) GASTROINTESTINAL RISK NSAIDS, INCLUDING DICLOFENAC SODIUM TOPICAL SOLUTION CAUSE AN INCREASED RISK OF SERIOUS GASTROINTESTINAL ADVERSE EVENTS INCLUDING BLEEDING, ULCERATION, AND PERFORATION OF THE STOMACH OR INTESTINES, WHICH CAN BE FATAL. THESE EVENTS CAN OCCUR AT ANY TIME DURING USE AND WITHOUT WARNING SYMPTOMS. ELDERLY PATIENTS ARE AT GREATER RISK FOR SERIOUS GASTROINTESTINAL EVENTS. ( 5.2) RECENT MAJOR CHANGES Dosage and Administration ( 2) 10/2013 INDICATIONS AND USAGE Diclofenac sodium topical solution is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s). ( 1) DOSAGE AND ADMINISTRATION FOR THE RELIEF OF THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS OF THE KNEE(S), THE RECOMMENDED DOSE IS 40 DROPS ON EACH PAINFUL KNEE, 4 TIMES A DAY. ( 2) Apply diclofenac sodium topical solution to clean, dry skin. ( 2.1) Dispense diclofenac sodium topical solution 10 drops at a time either directly onto the knee or first into the hand and then onto the knee. Spread diclofenac s Pročitajte cijeli dokument